- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske forsøg sponsoreret af Institute of Medicine and Biotechnology, Chinese Academy of Medical Sciences
I alt 1034 resultater
-
Jiangsu HengRui Medicine Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Chinese...Afsluttet
-
GeneCast Biotechnology Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical SciencesRekruttering
-
Academy Military Medical Science, ChinaCancer Institute and Hospital, Chinese Academy of Medical SciencesUkendt
-
China Academy of Chinese Medical SciencesBeijing University of Chinese MedicineUkendtSlag | Koronar sygdom | Hjertekrampe | Intrakraniel emboli | Vasospasme
-
Guangzhou University of Traditional Chinese MedicineCancer Institute and Hospital, Chinese Academy of Medical SciencesUkendt
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringSpiserørskræft | Kemoterapi | Immunterapi | Kemoradioterapi | NimotuzumabKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringEndometriekarcinom | Tilbagevendende eller metastatisk | TP53 mutationKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnuTrippel-negativ brystkræft i tidligt stadium med BRCA1/2-mutationerKina
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnuLipider | Ung brystkræftpatient | Anti-tumor lægemiddelterapi
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringAdenocarcinom i bugspytkirtlen | Avanceret kræft | Stofbrug | Capecitabin | Oxaliplatin | Første linje | Cadonilimab | Nanoliposomal irinotecanKina
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnuBugspytkirtelkræft
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnu
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringHepatocellulært karcinom | Strålebehandling | Tislelizumab | Tumor tromboseKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringMetastatisk tyktarmskræftKina
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnuIkke småcellet lungekræft | ERBB2 mutationsrelaterede tumorer | Disitamab Vedotin | ERBB2 genduplikering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringPlanocellulært karcinom i hoved og halsKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringPlanocellulært karcinom i hoved og halsKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringLokalt tilbagevendende tyktarmskræftKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringMålrettet terapi | HR+/HER2- Avanceret brystkræftKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringAvanceret lungekarcinomKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringBrystkræft | Kemoterapi effektKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringNasopharyngealt karcinomKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringPatienter med avancerede solide tumorerKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringSarkom, blødt væv | Bagagerum | Ekstremitet | Intensitetsmoduleret strålebehandling | Større sårkomplikationer | Målrettet terapiKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnu
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringMetastatisk tyktarmskræftKina
-
Cancer Institute and Hospital, Chinese Academy...Rekruttering
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringHormonreceptor positiv avanceret brystkræftKina
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnuRefraktær lymfom | DLBCL | MYD88 genmutation | Tilbagefald | CD79A genmutation | CD79B genmutation
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnuHepatocellulært karcinom resektabelt
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringEsophageal pladecellekarcinomKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringSpiserørskræft | Kemoradiation | Kirurgi | Kemoterapi effekt | Immunterapi | Målrettet terapi | Esophagogastric Juction CancerKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringLokalt avanceret ikke-småcellet lungekræftKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringAvanceret hepatocellulært karcinom | Strålebehandling | Sorafenib | ToripalimabKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringUbehandlede avancerede NSCLC-patienter | FISH Identificeret ALK Fusion Positiv eller NegativKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringTredobbelt negativ brystkræftKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringTredobbelt negativ brystkræftKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringHER2-positiv brystkræftKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringSamtidig kemoradioterapi | Nasopharynx pladecellekarcinom | Fase II, III | Induktionskemoterapi | Reducer behandlingsintensitetenKina
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnuHepatocellulært karcinomKina
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnuLokalt avanceret bugspytkirtelkræftKina
-
Cancer Institute and Hospital, Chinese Academy...RekrutteringBrystneoplasmer | Neoplasma gentagelse, lokalKina